Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-018833
Filing Date
2017-03-07
Accepted
2017-03-07 17:08:59
Documents
1
Period of Report
2017-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8526
  Complete submission text file 0001209191-17-018833.txt   10132
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Issuer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OPKO HEALTH, INC. 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address
PAGANELLI JOHN A (Reporting) CIK: 0001236687 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33528 | Film No.: 17672849